GART Antikörper (AA 1-433)

Produktnummer ABIN560998

Produktdetails anti-GART Antikörper

Target: GART (Phosphoribosylglycinamide Formyltransferase (GART))

Bindungsspezifität: AA 1-433

Reaktivität: Human

Wirt: Maus

Klonalität: Monoklonal

Konjugat: Dieser GART Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), ELISA, Immunofluorescence (IF), Immunoprecipitation (IP), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Verwendungszweck: Mouse monoclonal antibody raised against a full length recombinant GART.

Sequenz: MAARVLIIGS GGREHTLAWK LAQSHHVKQV LVAPGNAGTA CSEKISNTAI SISDHTALAQ FCKEKKIEFV VVGPEAPLAA GIVGNLRSAG VQCFGPTAEA AQLESSKRFA KEFMDRHGIP TAQWKAFTKP EEACSFILSA DFPALVVKAS GLAAGKGVIV AKSKEEACKA VQEIMQEKAF GAAGETIVIE ELLDGEEVSC LCFTDGKTVA PMPPAQDHKR LLEGDGGPNT GGMGAYCPAP QVSNDLLLKI KDTVLQRTVD GMQQEGTPYT GILYAGIMLT KNGPKVLEFN CRFGDPECQV ILPLLKSDLY EVIQSTLDGL LCTSLPVWLE NHTALTVVMA SKGYPGDYTK GVEITGFPEA QALGLEVFHA GTALKNGKVV THGGRVLAVT AIRENLISAL EEAKKGLAAI KFEGAIYRKD VGFRAIAFLQ QPR

Kreuzreaktivität: Human

Produktmerkmale: Antibody Reactive Against Recombinant Protein.

Immunogen: GART (AAH38958.1, 1 a.a. ~ 433 a.a) full-length recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.

Klon: 4D6-1D5

Isotyp: IgG1

Anwendungsinformationen

Applikationshinweise: Optimal working dilution should be determined by the investigator.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Buffer: In 1x PBS, pH 7.4

Handhabung: Aliquot to avoid repeated freezing and thawing.

Lagerung: -20 °C

Informationen zur Lagerung: Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.

Referenzen für anti-GART Antikörper (ABIN560998)

Baresova, Krijt, Skopova, Souckova, Kmoch, Zikanova: "CRISPR-Cas9 induced mutations along de novo purine synthesis in HeLa cells result in accumulation of individual enzyme substrates and affect purinosome formation." in: Molecular genetics and metabolism, Vol. 119, Issue 3, pp. 270-277, (2016) (PubMed).

Genovese, Gualandi, Taddia, Marverti, Pirondi, Marraccini, Perco, Pelà, Guerrini, Amoroso, Esposito, Martello, Ponterini, DArca, Costi: "Mass spectrometric/bioinformatic identification of a protein subset that characterizes the cellular activity of anticancer peptides." in: Journal of proteome research, Vol. 13, Issue 11, pp. 5250-61, (2014) (PubMed).

Banerjee, Ghosh, Chatterjee, Sinha, Nandagopal: "No Evidence for Mutations that Deregulate GARS-AIRS-GART Protein Levels in Children with Down Syndrome." in: Indian journal of clinical biochemistry : IJCB, Vol. 27, Issue 1, pp. 46-51, (2013) (PubMed).

Noelker, Schwake, Balzer-Geldsetzer, Bacher, Popp, Schlegel, Eggert, Oertel, Klockgether, Dodel: "Differentially expressed gene profile in the 6-hydroxy-dopamine-induced cell culture model of Parkinson's disease." in: Neuroscience letters, Vol. 507, Issue 1, pp. 10-5, (2012) (PubMed).

Field, Anguera, Page, Stover: "5,10-Methenyltetrahydrofolate synthetase activity is increased in tumors and modifies the efficacy of antipurine LY309887." in: Archives of biochemistry and biophysics, Vol. 481, Issue 2, pp. 145-50, (2009) (PubMed).

Details zu GART

Target: GART (Phosphoribosylglycinamide Formyltransferase (GART))

Andere Bezeichnung: GART (GART Produkte)

Hintergrund: Full Gene Name: phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase
Synonyms: AIRS,GARS,GARTF,MGC47764,PAIS,PGFT,PRGS

Gen-ID: 2618